{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:20:41Z","timestamp":1785349241278,"version":"3.55.0"},"reference-count":68,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,12]]},"DOI":"10.20945\/2359-3997000000352","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T19:20:30Z","timestamp":1619464830000},"source":"Crossref","is-referenced-by-count":7,"title":["Management of thyroid disorders during the COVID-19 outbreak: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM)"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0204-3552","authenticated-orcid":false,"given":"Jo\u00e3o Roberto M.","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4173-7258","authenticated-orcid":false,"given":"Danilo G. P.","family":"Villagelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2387-665X","authenticated-orcid":false,"given":"Gisah A.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6835-7108","authenticated-orcid":false,"given":"Fernanda","family":"Vaisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8859-6387","authenticated-orcid":false,"given":"Patr\u00edcia F. S.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8858-309X","authenticated-orcid":false,"given":"Rafael S.","family":"Scheffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7187-984X","authenticated-orcid":false,"given":"Jos\u00e9 A.","family":"Sgarbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"issue":"7798","key":"key20210426151634_B1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","unstructured":"Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020 Mar;579(7798):265-9.","journal-title":"Nature"},{"key":"key20210426151634_B2","volume-title":"Minist\u00e9rio da Sa\u00fade. Coronav\u00edrus Brasil: painel coronav\u00edrus [Internet]","author":"Brasil","year":"2020","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Coronav\u00edrus Brasil: painel coronav\u00edrus [Internet]. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade; 2020. [citado 13 maio 2020]. Dispon\u00edvel em: https:\/\/covid.saude.gov.br\/."},{"key":"key20210426151634_B3","author":"Johns Hopkins University","unstructured":"Johns Hopkins University. COVID-19 Map. Johns Hopkins Coronavirus Resource Center. [https:\/\/coronavirus.jhu.edu\/map.html]","journal-title":"COVID-19 Map. Johns Hopkins Coronavirus Resource Center"},{"key":"key20210426151634_B4","doi-asserted-by":"crossref","first-page":"dgaa148","DOI":"10.1210\/clinem\/dgaa148","article-title":"Our Response to COVID-19 as Endocrinologists and Diabetologists","volume":"105","author":"Kaiser","year":"2020","unstructured":"Kaiser UB, Mirmira RG, Stewart PM. Our Response to COVID-19 as Endocrinologists and Diabetologists. J Clin Endocrinol Metab. 2020;105:dgaa148.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20210426151634_B5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.15605\/jafes.035.01.10","article-title":"AFES AS-ONE: ASEAN Survey of Needs in Endocrinology in the time of the COVID-19 pandemic","volume":"35","author":"Jasul","year":"2020","unstructured":"Jasul Jr G, Paz-Pacheco E, Jimeno C, Suastika K, Hussein Z, Mustafa N, et al. AFES AS-ONE: ASEAN Survey of Needs in Endocrinology in the time of the COVID-19 pandemic. J ASEAN Fed Endocr Soc. 2020;35:5-13.","journal-title":"J ASEAN Fed Endocr Soc"},{"key":"key20210426151634_B6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/ct.2020;32.154-155","article-title":"COVID-19 and How It Is Affecting Me as a Thyroidologist","volume":"32","author":"Hennessey","year":"2020","unstructured":"Hennessey JV. COVID-19 and How It Is Affecting Me as a Thyroidologist. Clin Thyroidol. 2020;32:154-5.","journal-title":"Clin Thyroidol"},{"issue":"4","key":"key20210426151634_B7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11154-020-09569-2","article-title":"Endocrine and metabolic aspects of the COVID-19 pandemic","volume":"21","author":"Marazuela","year":"2020","unstructured":"Marazuela M, Giustina A, Puig-Domingo M. Endocrine and metabolic aspects of the COVID-19 pandemic. Rev Endocr Metab Disord. 2020;21(4):495-507.","journal-title":"Rev Endocr Metab Disord"},{"key":"key20210426151634_B8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12020-020-02294-5","article-title":"COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology","volume":"68","author":"Puig-Domingo","year":"2020","unstructured":"Puig-Domingo M, Marazuela M, Giustina A. COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine. 2020;68:2-5.","journal-title":"Endocrine"},{"key":"key20210426151634_B9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/postgradmedj-2020-137934","article-title":"Endocrine changes in SARS-CoV-2 patients and lessons from SARS-CoV","volume":"96","author":"Agarwal","year":"2020","unstructured":"Agarwal S, Agarwal SK. Endocrine changes in SARS-CoV-2 patients and lessons from SARS-CoV. Postgrad Med J. 2020;96:412-6.","journal-title":"Postgrad Med J"},{"key":"key20210426151634_B10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/1753-0407.13027","article-title":"Diabetes and COVID-19","volume":"12","author":"Bloomgarden","year":"2020","unstructured":"Bloomgarden ZT. Diabetes and COVID-19. J Diabetes. 2020;12:347-8.","journal-title":"J Diabetes"},{"key":"key20210426151634_B11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dsx.2020.04.004","article-title":"Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations","volume":"14","author":"Singh","year":"2020","unstructured":"Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020;14:303-10.","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"key20210426151634_B12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jmv.26237","article-title":"Obesity aggravates COVID-19: a systematic review and meta-analysis","volume":"93","author":"Yang","year":"2021","unstructured":"Yang J, Hu J, Zhu C. Obesity aggravates COVID-19: a systematic review and meta-analysis. J Med Virol. 2021 Jan;93(1):257-61.","journal-title":"J Med Virol"},{"key":"key20210426151634_B13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12020-020-02364-8","article-title":"Thyroid disease in the time of COVID-19","volume":"68","author":"Dworakowska","year":"2020","unstructured":"Dworakowska D, Grossman AB. Thyroid disease in the time of COVID-19. Endocrine. 2020;68:471-4.","journal-title":"Endocrine"},{"key":"key20210426151634_B14","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s40618-020-01276-8","article-title":"COVID-19 and the endocrine system: exploring the unexplored","volume":"43","author":"Pal","year":"2020","unstructured":"Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020;43:1027-31.","journal-title":"J Endocrinol Invest"},{"key":"key20210426151634_B15","first-page":"S83","article-title":"Endocrine vigilance in COVID-19","volume":"70","author":"Velayoudom","year":"2020","unstructured":"Velayoudom FL, Alwis Wijewickrama PS, Ranathunga HI, Somasundaram N. Endocrine vigilance in COVID-19. J Pak Med Assoc. 2020;70(Suppl 3):S83-S86.","journal-title":"J Pak Med Assoc"},{"key":"key20210426151634_B16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1055\/a-1172-1352","article-title":"Endocrine Conditions and COVID-19","volume":"52","author":"Shekhar","year":"2020","unstructured":"Shekhar S, Wurth R, Kamilaris CD, Eisenhofer G, Barrera FJ, Hajdenberg M, et al. Endocrine Conditions and COVID-19. Horm Metab Res. 2020;52:471-84.","journal-title":"Horm Metab Res"},{"key":"key20210426151634_B17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1089\/thy.2020.0363","article-title":"Thyroid function analysis in 50 patients with COVID-19: a retrospective study","volume":"31","author":"Chen","year":"2021","unstructured":"Chen M, Zhou W, Xu W. Thyroid function analysis in 50 patients with COVID-19: a retrospective study. Thyroid. 2021;31:8-11.","journal-title":"Thyroid"},{"key":"key20210426151634_B18","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s40618-020-01316-3","article-title":"A case of subacute thyroiditis associated with Covid-19 infection","volume":"43","author":"Asfuroglu Kalkan","year":"2020","unstructured":"Asfuroglu Kalkan E, Ates I. A case of subacute thyroiditis associated with Covid-19 infection. J Endocrinol Invest. 2020;43:1173-4.","journal-title":"J Endocrinol Invest"},{"key":"key20210426151634_B19","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s40618-020-01312-7","article-title":"SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report","volume":"43","author":"Ippolito","year":"2020","unstructured":"Ippolito S, Dentali F, Tanda ML. SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. J Endocrinol Invest. 2020;43:1171-2.","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"key20210426151634_B20","doi-asserted-by":"crossref","first-page":"dgaa276","DOI":"10.1210\/clinem\/dgaa276","article-title":"Subacute Thyroiditis After Sars-COV-2 Infection","volume":"105","author":"Brancatella","year":"2020","unstructured":"Brancatella A, Ricci D, Viola N, Sgr\u00f2 D, Santini F, Latrofa F. Subacute Thyroiditis After Sars-COV-2 Infection. J Clin Endocrinol Metab. 2020;105(7):dgaa276.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key20210426151634_B21","first-page":"dgaa537","article-title":"Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? Insights from a case series [published online ahead of print, 2020 Aug 11]","volume":"105","author":"Brancatella","year":"2020","unstructured":"Brancatella A, Ricci D, Cappellani D, Viola N, Sgr\u00f2 D, Santini F, et al. Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? Insights from a case series [published online ahead of print, 2020 Aug 11]. J Clin Endocrinol Metab. 2020 Oct 1;105(10):dgaa537.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20210426151634_B22","doi-asserted-by":"crossref","DOI":"10.11622\/smedj.2020106","article-title":"COVID-19 complicated by Hashimoto\u2019s thyroiditis","author":"Tee","year":"2020","unstructured":"Tee LY, Hajanto S, Rosario BH. COVID-19 complicated by Hashimoto\u2019s thyroiditis. Singapore Med J. 2020 Jul 16. doi: 10.11622\/smedj.2020106. Epub ahead of print.","journal-title":"Singapore Med J"},{"key":"key20210426151634_B23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1530\/EJE-20-0335","article-title":"Thyrotoxicosis in patients with COVID-19: the THYRCOV study","volume":"183","author":"Lania","year":"2020","unstructured":"Lania A, Sandri MT, Cellini M, Mirani M, Lavezzi E, Mazziotti G. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. 2020;183:381-7.","journal-title":"Eur J Endocrinol"},{"key":"key20210426151634_B24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor","year":"2018","unstructured":"Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018;14:301-16.","journal-title":"Nat Rev Endocrinol"},{"key":"key20210426151634_B25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2265.2007.02816.x","article-title":"Low prevalence of hypothyroidism among black and Mulatto people in a population-based study of Brazilian women","volume":"66","author":"Sichieri","year":"2007","unstructured":"Sichieri R, Baima J, Marante T, de Vasconcellos MT, Moura AS, Vaisman M. Low prevalence of hypothyroidism among black and Mulatto people in a population-based study of Brazilian women. Clin Endocrinol. 2007;66:803-7.","journal-title":"Clin Endocrinol"},{"key":"key20210426151634_B26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1590\/1414-431x20154445","article-title":"Gender, race and socioeconomic influence on diagnosis and treatment of thyroid disorders in the Brazilian Longitudinal Study of Adult Health (ELSA-Brazil)","volume":"48","author":"Olmos","year":"2015","unstructured":"Olmos RD, Figueiredo RC, Aquino EM, Lotufo PA, Bensenor IM. Gender, race and socioeconomic influence on diagnosis and treatment of thyroid disorders in the Brazilian Longitudinal Study of Adult Health (ELSA-Brazil). Braz J Med Biol Res. 2015;48:751-8.","journal-title":"Braz J Med Biol Res"},{"key":"key20210426151634_B27","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1530\/EJE-09-0845","article-title":"Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up: the Japanese-Brazilian thyroid study","volume":"162","author":"Sgarbi","year":"2010","unstructured":"Sgarbi JA, Matsumura LK, Kasamatsu TS, Ferreira SR, Maciel RM. Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up: the Japanese-Brazilian thyroid study. Eur J Endocrinol. 2010;162:569-77.","journal-title":"Eur J Endocrinol"},{"key":"key20210426151634_B28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fendo.2012.00008","article-title":"New Insights toward the Acute Non-Thyroidal Illness Syndrome","volume":"3","author":"Wajner","year":"2012","unstructured":"Wajner SM, Maia AL. New Insights toward the Acute Non-Thyroidal Illness Syndrome. Front Endocrinol (Lausanne). 2012 Jan 26;3:8.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"key20210426151634_B29","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1007\/s10096-020-03967-9","article-title":"Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: diagnostic value in organ injuries","volume":"39","author":"Li","year":"2020","unstructured":"Li T, Wang L, Wang H, Gao Y, Hu X, Li X, et al. Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: diagnostic value in organ injuries. Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2447-55.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key20210426151634_B30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(20)30266-7","article-title":"SARS-CoV-2-related atypical thyroiditis","volume":"8","author":"Muller","year":"2020","unstructured":"Muller I, Cannavaro D, Dazzi D, Covelli D, Mantovani G, Muscatello A, et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 2020;8:739-41.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"key20210426151634_B31","first-page":"1","article-title":"Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic","volume":"16","author":"Ruggeri","year":"2020","unstructured":"Ruggeri RM, Campenn\u00ec A, Siracusa M, Frazzetto G, Gullo D. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones (Athens). 2020;16:1-3.","journal-title":"Hormones (Athens)"},{"key":"key20210426151634_B32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/trp.trp_35_20","article-title":"Management of thyroid diseases during pandemic: A narrative review","volume":"17","author":"John","year":"2020","unstructured":"John M, Veetil VM. Management of thyroid diseases during pandemic: A narrative review. Thyroid Res Pract. 2020;17:62-9.","journal-title":"Thyroid Res Pract"},{"issue":"1","key":"key20210426151634_B33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40249-020-00662-x","article-title":"Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues","volume":"9","author":"Li","year":"2020","unstructured":"Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(1):45.","journal-title":"Infect Dis Poverty"},{"key":"key20210426151634_B34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ccc.2018.11.012","article-title":"Thyroid Hormones in Critical Illness","volume":"35","author":"Maiden","year":"2019","unstructured":"Maiden MJ, Torpy DJ. Thyroid Hormones in Critical Illness. Crit Care Clin. 2019;35:375-88.","journal-title":"Crit Care Clin"},{"key":"key20210426151634_B35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1186\/s13063-020-04474-0","article-title":"Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Pantos","year":"2020","unstructured":"Pantos C, Kostopanagiotou G, Armaganidis A, Trikas A, Tseti I, Mourouzis I. Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21:573.","journal-title":"Trials"},{"key":"key20210426151634_B36","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis","volume":"26","author":"Ross","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26:1343-421.","journal-title":"Thyroid"},{"key":"key20210426151634_B37","unstructured":"Sociedade Brasileira de Reumatologia, Grupo de Estudos da Doen\u00e7a Inflamat\u00f3ria Intestinal do Brasil e Sociedade Brasileira de Dermatologia. Atualiza\u00e7\u00e3o das recomenda\u00e7\u00f5es para profissionais de sa\u00fade e pacientes com doen\u00e7as imunomediadas reumatol\u00f3gicas, dermatol\u00f3gicas e doen\u00e7as intestinais inflamat\u00f3rias frente \u00e0 infec\u00e7\u00e3o pelo novo coronav\u00edrus. Available from: http:\/\/www.sbd.org.br\/mm\/cms\/2020\/03\/22\/atualizacao-covid-19.pdf.","journal-title":"Sociedade Brasileira de Reumatologia, Grupo de Estudos da Doen\u00e7a Inflamat\u00f3ria Intestinal do Brasil e Sociedade Brasileira de Dermatologia. Atualiza\u00e7\u00e3o das recomenda\u00e7\u00f5es para profissionais de sa\u00fade e pacientes com doen\u00e7as imunomediadas reumatol\u00f3gicas, dermatol\u00f3gicas e doen\u00e7as intestinais inflamat\u00f3rias frente \u00e0 infec\u00e7\u00e3o pelo novo coronav\u00edrus"},{"key":"key20210426151634_B38","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(17)30703-1","article-title":"Hypothyroidism","volume":"390","author":"Chaker","year":"2017","unstructured":"Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390:1550-62.","journal-title":"Lancet"},{"key":"key20210426151634_B39","author":"British Thyroid Foundation","unstructured":"British Thyroid Foundation. Thyroid disease and coronavirus (COVID-19) 4 May 2020. Available from: https:\/\/www.btf-thyroid.org\/news\/thyroid-disease-and-coronavirus-covid-19).","journal-title":"Thyroid disease and coronavirus (COVID-19) 4 May 2020"},{"issue":"1","key":"key20210426151634_B40","doi-asserted-by":"crossref","first-page":"G33","DOI":"10.1530\/EJE-20-0445","article-title":"Endocrinology in the Time of COVID-19: Management of hyper and hypothyroidism","volume":"183","author":"Boelaert","year":"2020","unstructured":"Boelaert K, Visser WE, Taylor PN, Moran C, L\u00e9ger J, Persani L. Endocrinology in the Time of COVID-19: Management of hyper and hypothyroidism. Eur J Endocrinol. 2020;183(1):G33-G39.","journal-title":"Eur J Endocrinol"},{"key":"key20210426151634_B41","author":"COVID crisis (American Thyroid Associtiation","unstructured":"COVID crisis (American Thyroid Associtiation. Novel coronavirus (COVID-19) and the thyroid:Resources. Available from: https:\/\/www.thyroid.org\/covid-19\/).","journal-title":"Novel coronavirus (COVID-19) and the thyroid:Resources"},{"key":"key20210426151634_B42","author":"American Association of Clinical Endocrinologists","unstructured":"American Association of Clinical Endocrinologists. AACE position statement: Coronavirus and people with thyroid disease. Available from: https:\/\/WWW.aace.com\/recent-news-and-update\/aace-position-statement-coronavirus-covid-19-and-people-thyroid-disease).","journal-title":"AACE position statement: Coronavirus and people with thyroid disease"},{"key":"key20210426151634_B43","doi-asserted-by":"crossref","first-page":"dgaa373","DOI":"10.1210\/clinem\/dgaa373","article-title":"Approach to the Patient with Thyrotoxicosis Using Telemedicine","volume":"105","author":"Griffith","year":"2020","unstructured":"Griffith ML, Bischoff LA, Baum HBA. Approach to the Patient with Thyrotoxicosis Using Telemedicine. J Clin Endocrinol Metab. 2020;105:dgaa373.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20210426151634_B44","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 Disease","volume":"375","author":"Smith","year":"2016","unstructured":"Smith TJ, Heged\u00fcs L. Graves\u2019 Disease. N Engl J Med. 2016;375:1552-65.","journal-title":"N Engl J Med"},{"issue":"8","key":"key20210426151634_B45","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s40618-020-01293-7","article-title":"Management of Graves\u2019 Hyperthyroidism and Orbitopathy in Time of COVID-19 Pandemic","volume":"43","author":"Bartalena","year":"2020","unstructured":"Bartalena L, Chiovato L, Marcocci C, Vitti P, Piantanida E, Tanda ML. Management of Graves\u2019 Hyperthyroidism and Orbitopathy in Time of COVID-19 Pandemic. J Endocrinol Invest. 2020;43(8):1149-51.","journal-title":"J Endocrinol Invest"},{"key":"key20210426151634_B46","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1089\/thy.2015.0195","article-title":"Outcomes in Relapsed Graves\u2019 Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment","volume":"25","author":"Villagelin","year":"2015","unstructured":"Villagelin D, Romaldini JH, Santos RB, Milkos AB, Ward LS. Outcomes in Relapsed Graves\u2019 Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment. Thyroid. 2015;25:1282-90.","journal-title":"Thyroid"},{"issue":"3","key":"key20210426151634_B47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12020-020-02364-8","article-title":"Thyroid disease in the time of COVID-19","volume":"68","author":"Dworakowska","year":"2020","unstructured":"Dworakowska D, Grossman AB. Thyroid disease in the time of COVID-19. Endocrine. 2020;68(3):471-4.","journal-title":"Endocrine"},{"key":"key20210426151634_B48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/thy.1998.8.37","article-title":"The significant increase in incidence of Graves\u2019 disease in eastern Serbia during the civil war in the former Yugoslavia (1992 to 1995)","volume":"8","author":"Paunkovic","year":"1998","unstructured":"Paunkovic N, Paunkovic J, Pavlovic O, Paunovic Z. The significant increase in incidence of Graves\u2019 disease in eastern Serbia during the civil war in the former Yugoslavia (1992 to 1995). Thyroid. 1998;8:37-41.","journal-title":"Thyroid"},{"key":"key20210426151634_B49","doi-asserted-by":"crossref","first-page":"747","DOI":"10.7326\/0003-4819-48-4-747","article-title":"Incidence of thyrotoxicosis among refugees from Nazi prison camps","volume":"48","author":"Weiman","year":"1958","unstructured":"Weiman SA. Incidence of thyrotoxicosis among refugees from Nazi prison camps. Ann Intern Med. 1958;48:747-52.","journal-title":"Ann Intern Med"},{"key":"key20210426151634_B50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1590\/S0004-27302013000300006","article-title":"Brazilian Society of Endocrinology and Metabolism. The Brazilian consensus for the diagnosis and treatment of hyperthyroidism: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism","volume":"57","author":"Maia","year":"2013","unstructured":"Maia AL, Scheffel RS, Meyer EL, Mazeto GM, Carvalho GA, Graf H, et al.; Brazilian Society of Endocrinology and Metabolism. The Brazilian consensus for the diagnosis and treatment of hyperthyroidism: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism. Arq Bras Endocrinol Metabol. 2013;57:205-32.","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"key20210426151634_B51","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fendo.2014.00102","article-title":"Clinical concepts on thyroid emergencies","volume":"5","author":"Papi","year":"2014","unstructured":"Papi G, Corsello SM, Pontecorvi A. Clinical concepts on thyroid emergencies. Front Endocrinol (Lausanne). 2014 Jul 1;5:102.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"key20210426151634_B52","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with Covid-19","volume":"384","author":"RECOVERY Collaborative Group","year":"2021","unstructured":"RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384(8):693-704.","journal-title":"N Engl J Med"},{"issue":"1","key":"key20210426151634_B53","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1186\/s13054-020-03400-9","article-title":"Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes","volume":"24","author":"van Paassen","year":"2020","unstructured":"van Paassen J, Vos JS, Hoekstra EM, Neumann KM, Boot PC, Arbous SM. Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes. Crit Care. 2020 Dec 14;24(1):696.","journal-title":"Crit Care"},{"key":"key20210426151634_B54","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1210\/jc.2003-031981","article-title":"Rapid preoperative preparation for severe hyperthyroid Graves\u2019 disease","volume":"89","author":"Panzer","year":"2004","unstructured":"Panzer C, Beazley R, Braverman L. Rapid preoperative preparation for severe hyperthyroid Graves\u2019 disease. J Clin Endocrinol Metab. 2004;89:2142-4.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20210426151634_B55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"European Group on Graves\u2019 Orbitopathy (EUGOGO). The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy Guidelines for the Management of Graves\u2019 Orbitopathy","volume":"5","author":"Bartalena","year":"2016","unstructured":"Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, et al.; European Group on Graves\u2019 Orbitopathy (EUGOGO). The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy Guidelines for the Management of Graves\u2019 Orbitopathy. Eur Thyroid J. 2016;5:9-26.","journal-title":"Eur Thyroid J"},{"issue":"5","key":"key20210426151634_B56","doi-asserted-by":"crossref","first-page":"102523","DOI":"10.1016\/j.autrev.2020.102523","article-title":"COVID-19 infection and rheumatoid arthritis: Faraway, so close!","volume":"19","author":"Favalli","year":"2020","unstructured":"Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R, Caporali R. COVID-19 infection and rheumatoid arthritis: Faraway, so close!. Autoimmun Rev. 2020 May;19(5):102523.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"key20210426151634_B57","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-217549","article-title":"Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia","volume":"80","author":"Guilpain","year":"2021","unstructured":"Guilpain P, Le Bihan C, Foulongne V, Taourel P, Pansu N, Maria ATJ, et al. Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia. Ann Rheum Dis. 2021 Jan;80(1):e10.","journal-title":"Ann Rheum Dis"},{"key":"key20210426151634_B58","first-page":"annrheumdis-2020-217864","article-title":"Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab","author":"Avouac","year":"2020","unstructured":"Avouac J, Air\u00f3 P, Carlier N, Matucci-Cerinic M, Allanore Y. Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab. Ann Rheum Dis. 2020 Jun 5:annrheumdis-2020-217864. doi: 10.1136\/annrheumdis-2020-217864. Epub ahead of print.","journal-title":"Ann Rheum Dis"},{"key":"key20210426151634_B59","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/thy.2018.0397","article-title":"Treatment of Toxic Multinodular Goiter: Comparison of Radioiodine and Long-Term Methimazole Treatment [published correction appears in Thyroid. 2019;29:1871]","volume":"29","author":"Azizi","year":"2019","unstructured":"Azizi F, Takyar M, Madreseh E, Amouzegar A. Treatment of Toxic Multinodular Goiter: Comparison of Radioiodine and Long-Term Methimazole Treatment [published correction appears in Thyroid. 2019;29:1871]. Thyroid. 2019;29:625-30.","journal-title":"Thyroid"},{"key":"key20210426151634_B60","first-page":"340","article-title":"Amiodarone and the thyroid: a 2012 update","volume":"35","author":"Bogazzi","year":"2012","unstructured":"Bogazzi F, Tomisti L, Bartalena L, Aghini-Lombardi F, Martino E. Amiodarone and the thyroid: a 2012 update. J Endocrinol Invest. 2012;35:340-8.","journal-title":"J Endocrinol Invest"},{"key":"key20210426151634_B61","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000486957","article-title":"2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction","volume":"7","author":"Bartalena","year":"2018","unstructured":"Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M. 2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction. Eur Thyroid J. 2018;7:55-66.","journal-title":"Eur Thyroid J"},{"key":"key20210426151634_B62","first-page":"1","article-title":"Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view","author":"Berton","year":"2020","unstructured":"Berton AM, Prencipe N, Giordano R, Ghigo E, Grottoli S. Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view. J Endocrinol Invest. 2020 Jun 8:1-3. doi: 10.1007\/s40618-020-01325-2. Epub ahead of print.","journal-title":"J Endocrinol Invest"},{"key":"key20210426151634_B63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1-133.","journal-title":"Thyroid"},{"key":"key20210426151634_B64","article-title":"Delays to Low-Risk Thyroid Cancer Treatment During COVID-19\u2014Refocusing From What Has Been Lost to What May Be Learned and Gained","author":"Nickel","year":"2020","unstructured":"Nickel B, Glover A, Miller JA. Delays to Low-Risk Thyroid Cancer Treatment During COVID-19\u2014Refocusing From What Has Been Lost to What May Be Learned and Gained. JAMA Otolaryngol Head Neck Surg. 2020 Oct 29. doi: 10.1001\/jamaoto.2020.3878. Epub ahead of print.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"7","key":"key20210426151634_B65","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/jso.26146","article-title":"Value of preoperative testing for SARS-CoV-2 for elective surgeries in a cancer center during the peak of pandemic in Brazil","volume":"122","author":"Aguiar","year":"2020","unstructured":"Aguiar S Junior, Baiocchi G, Duprat JP, Coimbra FJF, Makdissi FB, Vartanian JG, et al. Value of preoperative testing for SARS-CoV-2 for elective surgeries in a cancer center during the peak of pandemic in Brazil. J Surg Oncol. 2020;122(7):1293-5.","journal-title":"J Surg Oncol"},{"key":"key20210426151634_B66","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1089\/thy.2016.0038","article-title":"Timing Of Radioactive Iodine Therapy Does Not Impact Overall Survival In High-Risk Papillary Thyroid Carcinoma","volume":"26","author":"Scheffel","year":"2016","unstructured":"Scheffel RS, Zanella AB, Dora JM, Maia AL. Timing Of Radioactive Iodine Therapy Does Not Impact Overall Survival In High-Risk Papillary Thyroid Carcinoma. Thyroid. 2016;26:1623-9.","journal-title":"Thyroid"},{"key":"key20210426151634_B67","doi-asserted-by":"crossref","first-page":"822","DOI":"10.4158\/EP151088.OR","volume":"22","author":"Suman","year":"2016","unstructured":"Suman P, Wang CH, Abadin SS, Block R, Raghavan V, Moo-Young TA, et al. Endocr Pract. 2016;22:822-31.","journal-title":"Endocr Pract"},{"key":"key20210426151634_B68","unstructured":"Instituto de Radioprote\u00e7\u00e3o e Dosimetria, atos normativos. Available from: http:\/\/www.ird.gov.br\/index.php\/atos-normativos. Access on: Dec 22. 2020.","journal-title":"Instituto de Radioprote\u00e7\u00e3o e Dosimetria, atos normativos"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,12,25]],"date-time":"2022-12-25T13:29:28Z","timestamp":1671974968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972021005005208&lng=en&nrm=iso"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,12]]},"references-count":68,"alternative-id":["10.20945\/2359-3997000000352"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000352","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,12]]}}}